Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 50c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus

November 6, 2019 7:21 AM

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of $0.18, $0.50 better than the analyst estimate of ($0.32). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found